These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21299068)

  • 1. Galanin, galanin receptor subtypes and depression-like behaviour.
    Kuteeva E; Hökfelt T; Wardi T; Ogren SO
    Exp Suppl; 2010; 102():163-81. PubMed ID: 21299068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin, galanin receptor subtypes and depression-like behaviour.
    Kuteeva E; Hökfelt T; Wardi T; Ogren SO
    Cell Mol Life Sci; 2008 Jun; 65(12):1854-63. PubMed ID: 18500640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain galanin receptors: targets for novel antidepressant drugs.
    Lu X; Sharkey L; Bartfai T
    CNS Neurol Disord Drug Targets; 2007 Jun; 6(3):183-92. PubMed ID: 17511615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease.
    Karlsson RM; Holmes A
    Amino Acids; 2006 Oct; 31(3):231-9. PubMed ID: 16733616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanin, galanin receptors, and drug targets.
    Mitsukawa K; Lu X; Bartfai T
    Exp Suppl; 2010; 102():7-23. PubMed ID: 21299058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions.
    Šípková J; Kramáriková I; Hynie S; Klenerová V
    Physiol Res; 2017 Nov; 66(5):729-740. PubMed ID: 28730831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression.
    Flores-Burgess A; Millón C; Gago B; Narváez M; Borroto-Escuela DO; Mengod G; Narváez JA; Fuxe K; Santín L; Díaz-Cabiale Z
    Neuropharmacology; 2017 May; 118():233-241. PubMed ID: 28288814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level.
    Kuteeva E; Wardi T; Lundström L; Sollenberg U; Langel U; Hökfelt T; Ogren SO
    Neuropsychopharmacology; 2008 Oct; 33(11):2573-85. PubMed ID: 18172432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain.
    Rovin ML; Boss-Williams KA; Alisch RS; Ritchie JC; Weinshenker D; West CH; Weiss JM
    Neuropeptides; 2012 Apr; 46(2):81-91. PubMed ID: 22317959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galanin, galanin receptors and drug targets.
    Mitsukawa K; Lu X; Bartfai T
    Cell Mol Life Sci; 2008 Jun; 65(12):1796-805. PubMed ID: 18500647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
    Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic venlafaxine treatment fails to alter the levels of galanin system transcripts in normal rats.
    Petschner P; Juhasz G; Tamasi V; Adori C; Tothfalusi L; Hökfelt T; Bagdy G
    Neuropeptides; 2016 Jun; 57():65-70. PubMed ID: 26891823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin/GALP receptors and CNS homeostatic processes.
    Robinson JK; Bartfai T; Langel U
    CNS Neurol Disord Drug Targets; 2006 Jun; 5(3):327-34. PubMed ID: 16787232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests.
    Lu X; Ross B; Sanchez-Alavez M; Zorrilla EP; Bartfai T
    Neuropeptides; 2008 Aug; 42(4):387-97. PubMed ID: 18554714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy.
    Medel-Matus JS; Shin D; Sankar R; Mazarati A
    Exp Neurol; 2017 Mar; 289():64-72. PubMed ID: 28013000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel systemically active galanin receptor 2 ligands in depression-like behavior.
    Saar I; Lahe J; Langel K; Runesson J; Webling K; Järv J; Rytkönen J; Närvänen A; Bartfai T; Kurrikoff K; Langel Ü
    J Neurochem; 2013 Oct; 127(1):114-23. PubMed ID: 23600864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.
    Hawes JJ; Picciotto MR
    J Comp Neurol; 2004 Nov; 479(4):410-23. PubMed ID: 15514977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system.
    Millón C; Flores-Burgess A; Narváez M; Borroto-Escuela DO; Santín L; Gago B; Narváez JA; Fuxe K; Díaz-Cabiale Z
    Brain Struct Funct; 2016 Dec; 221(9):4491-4504. PubMed ID: 26792005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3.
    Kolakowski LF; O'Neill GP; Howard AD; Broussard SR; Sullivan KA; Feighner SD; Sawzdargo M; Nguyen T; Kargman S; Shiao LL; Hreniuk DL; Tan CP; Evans J; Abramovitz M; Chateauneuf A; Coulombe N; Ng G; Johnson MP; Tharian A; Khoshbouei H; George SR; Smith RG; O'Dowd BF
    J Neurochem; 1998 Dec; 71(6):2239-51. PubMed ID: 9832121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.